Jeffrey Wong, MD, discusses the unmet needs in prostate cancer treatment, especially in regard to radiopharmaceuticals.

Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

Medically reviewed by Jamin Brahmbhatt, MD Metastatic castration-resistant prostate cancer (mCRPC) is a type of advanced ...

But a new genetic test appears capable of sussing out which men are at greater risk of urinary side effects from radiation ...

A new study from Sunnybrook Health Sciences Centre and the University of Toronto has shown that high-resolution ultrasound is ...

A spit test, developed by London's Institute of Cancer Research, can help detect prostrate cancer better than the ...

If you have metastatic castration-resistant prostate cancer, the hormone therapy you’ve been taking is no longer controlling the disease as it should. Here’s what you should know. This type of ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was ...

Several risk factors contribute to the development of prostate cancer, many of which are common worldwide but can be influenced by specific local factors in Uganda. Thank you for reading Nation.Africa ...

Several biomarker tests have been available for over a decade, with extensive research backing their effectiveness. Yet, many ...

Guidelines created by a multi-disciplinary panel of specialists focus on implementation of novel treatments and technologies for which level 1 evidence is lacking.